南非大麻及大麻素产品研究的优先领域。
Priority areas for cannabis and cannabinoid product research in South Africa.
作者信息
Augustine Tanya N, Cairns Carel J, Chetty Sean, Dannatt Lisa G, Gravett Nadine, Grey Glenda, Grobler Gerhard, Jafta Zukiswa, Kamerman Peter, Lopes John, Matsabisa Motlalepula G, Mugabo Pierre, Mulder Michelle, Parry Charles, Rataemane Solomon, Siegfried Nandi, Steenkamp Vanessa, Thomas Eileen, Van Zyl-Smit Richard
机构信息
School of Anatomical Sciences, Faculty of Health Sciences, University of the Witwatersrand.
出版信息
Afr J Prim Health Care Fam Med. 2018 Jun 21;10(1):e1-e3. doi: 10.4102/phcfm.v10i1.1711.
Abstract
No abstract available.
摘要
无摘要。
相似文献
1
Priority areas for cannabis and cannabinoid product research in South Africa.南非大麻及大麻素产品研究的优先领域。
Afr J Prim Health Care Fam Med. 2018 Jun 21;10(1):e1-e3. doi: 10.4102/phcfm.v10i1.1711.
2
Medicinal cannabis and painful sensory neuropathy.药用大麻与疼痛性感觉神经病变
Virtual Mentor. 2013 May 1;15(5):466-9. doi: 10.1001/virtualmentor.2013.15.5.oped1-1305.
3
Cannabis and cannabinoids.大麻和大麻素。
Med Lett Drugs Ther. 2016 Aug 1;58(1500):97-8.
4
Cannabinoids: Medical implications.大麻素：医学意义。
Ann Med. 2016;48(3):128-41. doi: 10.3109/07853890.2016.1145794. Epub 2016 Feb 25.
5
Sequelae of Cannabis as Medicine.大麻作为药物的后遗症。
Pain Med. 2015 Jul;16(7):1447-9. doi: 10.1111/pme.12736. Epub 2015 Jun 24.
6
The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms.大麻和大麻素的药用用途--管理形式的国际横断面调查。
J Psychoactive Drugs. 2013 Jul-Aug;45(3):199-210. doi: 10.1080/02791072.2013.805976.
7
Plant, synthetic, and endogenous cannabinoids in medicine.医学中的植物性、合成性和内源性大麻素。
Annu Rev Med. 2006;57:553-74. doi: 10.1146/annurev.med.57.011205.135648.
8
Re-branding cannabis: the next generation of chronic pain medicine?重塑大麻品牌：新一代慢性疼痛药物？
Pain Manag. 2015;5(1):13-21. doi: 10.2217/pmt.14.49.
9
Medical uses of marijuana (Cannabis sativa): fact or fallacy?大麻（ Cannabis sativa）的医学用途：事实还是谬误？
Br J Biomed Sci. 2015;72(2):85-91. doi: 10.1080/09674845.2015.11666802.
10
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.医用大麻与慢性疼痛：基础科学与临床证据综述
Curr Pain Headache Rep. 2015 Oct;19(10):50. doi: 10.1007/s11916-015-0524-x.
引用本文的文献
1
Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection.植物大麻素：药理作用、生物医学应用及全球展望。
J Tradit Complement Med. 2023 Aug 26;13(6):575-587. doi: 10.1016/j.jtcme.2023.08.006. eCollection 2023 Nov.
2
Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.靶向内源性大麻素系统治疗HIV相关神经性疼痛：一项系统评价。
IBRO Neurosci Rep. 2021 Jan 25;10:109-118. doi: 10.1016/j.ibneur.2021.01.004. eCollection 2021 Jun.
本文引用的文献
1
The Question of Clinical Equipoise and Patients' Best Interests.临床 equipoise 与患者最佳利益问题
AMA J Ethics. 2015 Dec 1;17(12):1108-15. doi: 10.1001/journalofethics.2015.17.12.ecas1-1512.
2
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.医用大麻素：系统评价和荟萃分析。
JAMA. 2015;313(24):2456-73. doi: 10.1001/jama.2015.6358.
3
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.一项关于THC/CBD喷雾剂治疗周围神经性疼痛的双盲、随机、安慰剂对照平行组研究。
Eur J Pain. 2014 Aug;18(7):999-1012. doi: 10.1002/j.1532-2149.2013.00445.x. Epub 2014 Jan 13.
4
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.一项双盲、随机、安慰剂对照、平行分组研究，评估 THC/CBD 口腔黏膜喷雾剂联合现有治疗方案，缓解多发性硬化症患者中枢性神经病理性疼痛的疗效。
J Neurol. 2013 Apr;260(4):984-97. doi: 10.1007/s00415-012-6739-4. Epub 2012 Nov 21.
5
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.改善慢性疼痛临床试验中检测方法灵敏度的考虑因素：IMMPACT 建议。
Pain. 2012 Jun;153(6):1148-1158. doi: 10.1016/j.pain.2012.03.003. Epub 2012 Apr 9.
6
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.GRADE：关于证据质量评级和推荐强度的新共识。
BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.
Zotero 插件